Pro- and synbiotics to control inflammation and infection in patients with multiple injuries

Journal of Trauma - Injury, Infection and Critical Care

Volumn 67, Issue 4, 2009, Pages 815-821

  Giamarellos Bourboulis, Evangelos J ^a   Bengmark, Stig ^b   Kanellakopoulou, Kyriaki ^a   Kotzampassi, Katerina ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Bacteremia; Sepsis; Synbiotics; Ventilator associated pneumonia

Indexed keywords

2000FORTE; ALANYLGLUTAMINE; C REACTIVE PROTEIN; ENDOTOXIN; INSULIN; LIPOPOLYSACCHARIDE; PLACEBO; PROBIOTIC AGENT; SYNBIOTIC AGENT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ADULT; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; HUMAN; INFECTION; INFECTION CONTROL; INFLAMMATION; INJURY SEVERITY; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE TRAUMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VENTILATOR ASSOCIATED PNEUMONIA;

ACTINOBACTERIA; APACHE; BACTERIAL INFECTIONS; CRITICAL ILLNESS; CROSS INFECTION; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MIDDLE AGED; MULTIPLE TRAUMA; PNEUMONIA, VENTILATOR-ASSOCIATED; POLYSACCHARIDES; PROBIOTICS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 72449206050     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31819d979e     Document Type: Article

References (35)

1. Bengmark S. Bioecological control of inflammation and infection in critical illness. Anaesthesiol Clin. 2006;24:299-323.
2. Taneja R, Parodo J, Jia SH, Kapus A, Rotstein OD, Marshall JC. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med. 2004;32:1460-1469.
3. Sautner T, Fugger R, Getzinger P, et al. Tumour necrosis factor-alpha and interleukin-6: early indicators of bacterial infection after human orthotopic liver transplantation. Eur J Surg. 1995;161:97-101.
4. von der Weid T, Bulliard C, Schiffrin EJ. Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin. Clin Diagn Lab Immunol 2001;8:695-701.
5. Ibnou-Zekri N, Blum S, Schiffrin EJ, et al. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun. 2003;71:428-436.
6. Prioult G, Fliss I, Pecquet S. Effect of probiotic bacteria on induction and maintenance of oral tolerance to beta-lactoglobulin in gnotobiotic mice. Clin Diagn Lab Immunol. 2003;10:787-792.
7. Ljungh Å, Lan JG, Yamagisawa N. Isolation, selection and characteristics of Lactobacillus paracasei ssp paracasei isolate F19. Microb Ecol Health Dis. 2002; 14(suppl 3):4-6.
8. Kruszewska K, Lan J, Lorca G, Yanagisawa N, Marklinder I, Ljungh Å. Selection of lactic acid bacteria as probiotic strains by in vitro tests. Microecol Ther. 2002;29:37-51.
9. Fujiwara D, Inoue S, Wakabayashi H, Fujii T. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol. 2004;135:205-215.
10. Naaber P, Smidt I, Stsepetova J, Brilene T, Annuk H, Mikelsaar M. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. J Med Microbiol. 2004;53:551-554.
11. Tok D, Ilkgul O, Bengmark S, et al. Pretreatment with pro- and synbiotics reduces peritonitis-induce lung injury in rats. J Trauma. 2007;62:880-885.
12. Ilkgul O, Aydede H, Erhan Y, et al. Subcutaneous administration of live lactobacillus prevents sepsis-induced lung organ failure in rats. Br J Intensive Care. 2005;15:52-57.
13. Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation-a randomized, double-blind trial. Am J Transplant. 2005;5:125-130.
14. Rayes N, Seehofer D, Theruvath T, et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg. 2007;246:36-41.
15. Oláh A, Belágyi T, Pó tó L, Romics L Jr, Bengmark S. Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology. 2007;54:590-594.
16. Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN J Parenter Enteral Nutr. 2007;31:119-126.
17. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: results of a randomized controlled trial. World J Surg. 2006;30:1848-1855.
18. Fihn SD. Acute uncomplicated urinary tract infection in women. N Engl J Med. 2003;349:259-266.
19. Camargo LFA, De Marco FV, Barbas CS, et al. Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates. Crit Care. 2004;8:R422-R430.
20. Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P, et al. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect. 2004;10: 628-633.
21. Lee A, Mirrett S, Reller LB, Weinstein P. Detection of bloodstream infections in adults: how many blood cultures are needed? J Clin Microbiol. 2007;45:3546-3548.
22. Levy M, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/ SIS international sepsis definitions conference. Crit Care Med. 2003;31: 1250-1256. (Pubitemid 36444440)
23. Vincent JL. Ventilator-associated pneumonia. J Hosp Infect. 2004;57: 272-280.
24. Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator- associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991; 143:1121-1129.
25. Giamarellos-Bourboulis EJ, Pechère JC, Routsi C, et al. Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin Infect Dis. 2008;46:1157-1164.
26. Heczko PB, Strus M, Kochan P. Critical evaluation of probiotic activity of lactic acid bacteria and their effects. J Physiol Pharmacol. 2006; 57(suppl 9): 5-12.
27. Watkinson PJ, Barber VS, Dark P, Young JD. The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review. Clin Nutr. 2007;26:182-192.
28. Marotta F, Barreto R, Wu CC, et al. Experimental acute alcohol pancreatitis-induced liver damage and endotoxemia: synbiotics but not metronidazole have a protective effect. Chin J Dig Dis. 2005;6:193-197.
29. Eleftheriadis E, Kotzampassi K, Heliades N, et al. The implication of nitric oxide in the process of bacterial translocation. Int Surg. 2000;85: 23-26.
30. Eleftheriadis E, Kotzampassi K, Papanotas K, Heliadis N, Sarris K. Gut ischemia, oxidative stress, and bacterial translocation in elevated abdominal pressure in rats. World J Surg. 1996;20:11-16.
31. Koratzanis G, Giamarellos-Bourboulis EJ, Papalambros E, Giamarellou H. Bacterial translocation following intrabdominal surgery. Any influence of antimicrobial propylaxis? Int J Antimicrob Agents. 2002;20:457-460.
32. Balzan S, de Almediaq Uadros C, de Cleva R, Zilberstein B, Cecconello I. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol. 2006;22:464-471.
33. Magnotti LJ, Upperman JS, Xu DZ, Lu Q, Deitch EA. Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg. 1998;228:518-527.
34. Apostolou E, Kirjavainen PV, Saxelin M, et al. Good adhesion properties of probiotics: a potential risk for bacteremia? FEMS Immunol Med Microbiol. 2001;31:35-39.
35. Srivasan R, Meyer R, Padmanabhan R, Britto J. Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. J Pediatr Gastroenterol Nutr. 2006;42:171-173.